TY - JOUR
T1 - Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon
AU - Dey, Arunangsu
AU - Lipkind, Gregory M.
AU - Rouillé, Yves
AU - Norrbom, Christina
AU - Stein, Jeffrey
AU - Zhang, Chunling
AU - Carroll, Raymond
AU - Steiner, Donald F.
PY - 2005/2
Y1 - 2005/2
N2 - To define the biological significance of the initial cleavage at the proglucagon (PG) interdomain site, K70-R71 ↓, we created two interdomain mutants, K70Q-R71Q and R71A. Cotransfection studies in GH4C1 cells show significant amounts of glucagon production by PC2 along with some glicentin, glicentin-related polypeptide-glucagon (GRPP-glucagon) and oxyntomodulin from wild-type PG. In contrast, a larger peptide, PG 33-158, and low amounts of GRPP-glucagon are predominantly generated from interdomain mutants. HPLC analysis shows a 5-fold increase in glucagon production by PC2 from wild-type PG and a corresponding 4-fold lower accumulation and secretion of unprocessed precursor relative to interdomain mutants. PC2 generates significant levels of glucagon from a glicentin (PG 1-69) expression plasmid, whereas PC1/3 produces only modest amounts of oxyntomodulin. Employing a major PG fragment (PG 72-158) expression plasmid, we show that PC1/3 predominantly generates glucagon-like peptide (GLP)-1, whereas PC2 produces only N-terminally extended GLP-1. Surprisingly, production of GLP-1 and GLP-2 by PC1/3 from interdomain mutants, compared with wild-type PG, is not significantly impaired. In addition to PC2 and PC1/3, PC5/6A and furin are also able to cleave the sites, K70-R71 ↓ and R107-X-R-R110 ↓ in PG. We show a much greater ability of furin to cleave the monobasic site, R77 ↓, than at the dibasic site, R124-R125 ↓, which is also weakly processed by PC5/6A, indicating overlapping specificities of these two convertases mainly with PC1/3. We propose here a trimer-like model of the spatial organization of the hormonal sequences within the PG molecule in which the accessibility to prohormone convertase action of most cleavage sites is restricted with the exception of the interdomain site, K70-R71, which is maximally accessible.
AB - To define the biological significance of the initial cleavage at the proglucagon (PG) interdomain site, K70-R71 ↓, we created two interdomain mutants, K70Q-R71Q and R71A. Cotransfection studies in GH4C1 cells show significant amounts of glucagon production by PC2 along with some glicentin, glicentin-related polypeptide-glucagon (GRPP-glucagon) and oxyntomodulin from wild-type PG. In contrast, a larger peptide, PG 33-158, and low amounts of GRPP-glucagon are predominantly generated from interdomain mutants. HPLC analysis shows a 5-fold increase in glucagon production by PC2 from wild-type PG and a corresponding 4-fold lower accumulation and secretion of unprocessed precursor relative to interdomain mutants. PC2 generates significant levels of glucagon from a glicentin (PG 1-69) expression plasmid, whereas PC1/3 produces only modest amounts of oxyntomodulin. Employing a major PG fragment (PG 72-158) expression plasmid, we show that PC1/3 predominantly generates glucagon-like peptide (GLP)-1, whereas PC2 produces only N-terminally extended GLP-1. Surprisingly, production of GLP-1 and GLP-2 by PC1/3 from interdomain mutants, compared with wild-type PG, is not significantly impaired. In addition to PC2 and PC1/3, PC5/6A and furin are also able to cleave the sites, K70-R71 ↓ and R107-X-R-R110 ↓ in PG. We show a much greater ability of furin to cleave the monobasic site, R77 ↓, than at the dibasic site, R124-R125 ↓, which is also weakly processed by PC5/6A, indicating overlapping specificities of these two convertases mainly with PC1/3. We propose here a trimer-like model of the spatial organization of the hormonal sequences within the PG molecule in which the accessibility to prohormone convertase action of most cleavage sites is restricted with the exception of the interdomain site, K70-R71, which is maximally accessible.
UR - http://www.scopus.com/inward/record.url?scp=12344302029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12344302029&partnerID=8YFLogxK
U2 - 10.1210/en.2004-1118
DO - 10.1210/en.2004-1118
M3 - Article
C2 - 15528303
AN - SCOPUS:12344302029
SN - 0013-7227
VL - 146
SP - 713
EP - 727
JO - Endocrinology
JF - Endocrinology
IS - 2
ER -